Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/india-to-supply-generic-cancer-drug-to-us-chidanand-rajghatta-4677319/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/india-to-supply-generic-cancer-drug-to-us-chidanand-rajghatta-4677319/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/india-to-supply-generic-cancer-drug-to-us-chidanand-rajghatta-4677319/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/india-to-supply-generic-cancer-drug-to-us-chidanand-rajghatta-4677319/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f6df310dc35-trace').style.display = (document.getElementById('cakeErr67f6df310dc35-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f6df310dc35-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f6df310dc35-code').style.display = (document.getElementById('cakeErr67f6df310dc35-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f6df310dc35-context').style.display = (document.getElementById('cakeErr67f6df310dc35-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f6df310dc35-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f6df310dc35-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 29264,
		&#039;title&#039; =&gt; &#039;India to supply generic cancer drug to US -Chidanand Rajghatta&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;WASHINGTON: &lt;/em&gt;India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered for increasing the price of life-saving drugs by as much as 5000 per cent overnight.&lt;br /&gt;
&lt;br /&gt;
Martin Shkreli, CEO of Turing Pharmaceuticals, is being dubbed the &#039;&#039;poster child for price gouging in the pharma industry&#039;&#039; and BBC has asked if he is the &#039;&#039;the most hated man in America&#039;&#039; after he bumped up the price of Daraprim, a drug used to treat a parasitic diseases, from an already high $13.50 to $750. Daily Beast called him an &#039;&#039;asshole.&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
Although Turing has walked back from the price rise in the face of public anger, his actions have drawn attention to the strategy adopted by Big Pharma to buy out older drugs that are nearing patent loss and hike their price massively, with the argument that the money is needed to fund new research.&lt;br /&gt;
&lt;br /&gt;
On Tuesday, Hillary Clinton stepped up to the plate, offering proposals to control drug prices, even as her challenger Bernie Sanders and others have called for eliminating corporate restrictions on generics. Such a move will help both American patients and Indian drug manufacturers, who have constrained by Big Pharma with the familiar argument that it needs to recoup money spent on research, and generic makers profit from the work of Big Pharma.&lt;br /&gt;
&lt;br /&gt;
The full details of the US-India agreement was not disclosed, but Indian officials confirmed that New Delhi had agreed to supply an &#039;&#039;off-patent&#039;&#039; cancer drug. Such a move could be a template for the supply of life-saving pharmaceuticals to a US system that is overpriced and overburdened, causing untold suffering to millions of poor and middleclass Americans.&lt;br /&gt;
&lt;br /&gt;
The Pharma lobby is the biggest contributor of money to the US political systems and it is widely believed that many lawmakers are beholden to it in lieu of campaign contributions.&lt;br /&gt;
&lt;br /&gt;
India is the second largest exporter of drugs to the United States. In 2014, India held 13% share of the total 64,170 imported lines of pharmaceuticals, according to a US fact sheet. The United States spends close to $3 trillion - some 17% of its GDP - on healthcare, an expense that far exceeds even military spending.&lt;br /&gt;
&lt;br /&gt;
The two countries also agreed to a raft of measures, including creating and growing a cadre of field epidemiologists in India to prevent, detect, and respond to infectious disease threats. The US also pledged to engage with India on traditional medicine, health information systems, and agreed to launch a new collaboration on mental health. &lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 24 September, 2015, http://timesofindia.indiatimes.com/india/India-to-supply-generic-cancer-drug-to-US/articleshow/49083996.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;india-to-supply-generic-cancer-drug-to-us-chidanand-rajghatta-4677319&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4677319,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 29264,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | India to supply generic cancer drug to US -Chidanand Rajghatta&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Access to Health,Access to Healthcare,generic drugs,generic medicines&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India

WASHINGTON: India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;br /&gt;&lt;br /&gt;&lt;em&gt;WASHINGTON: &lt;/em&gt;India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered for increasing the price of life-saving drugs by as much as 5000 per cent overnight.&lt;br /&gt;&lt;br /&gt;Martin Shkreli, CEO of Turing Pharmaceuticals, is being dubbed the &#039;&#039;poster child for price gouging in the pharma industry&#039;&#039; and BBC has asked if he is the &#039;&#039;the most hated man in America&#039;&#039; after he bumped up the price of Daraprim, a drug used to treat a parasitic diseases, from an already high $13.50 to $750. Daily Beast called him an &#039;&#039;asshole.&#039;&#039;&lt;br /&gt;&lt;br /&gt;Although Turing has walked back from the price rise in the face of public anger, his actions have drawn attention to the strategy adopted by Big Pharma to buy out older drugs that are nearing patent loss and hike their price massively, with the argument that the money is needed to fund new research.&lt;br /&gt;&lt;br /&gt;On Tuesday, Hillary Clinton stepped up to the plate, offering proposals to control drug prices, even as her challenger Bernie Sanders and others have called for eliminating corporate restrictions on generics. Such a move will help both American patients and Indian drug manufacturers, who have constrained by Big Pharma with the familiar argument that it needs to recoup money spent on research, and generic makers profit from the work of Big Pharma.&lt;br /&gt;&lt;br /&gt;The full details of the US-India agreement was not disclosed, but Indian officials confirmed that New Delhi had agreed to supply an &#039;&#039;off-patent&#039;&#039; cancer drug. Such a move could be a template for the supply of life-saving pharmaceuticals to a US system that is overpriced and overburdened, causing untold suffering to millions of poor and middleclass Americans.&lt;br /&gt;&lt;br /&gt;The Pharma lobby is the biggest contributor of money to the US political systems and it is widely believed that many lawmakers are beholden to it in lieu of campaign contributions.&lt;br /&gt;&lt;br /&gt;India is the second largest exporter of drugs to the United States. In 2014, India held 13% share of the total 64,170 imported lines of pharmaceuticals, according to a US fact sheet. The United States spends close to $3 trillion - some 17% of its GDP - on healthcare, an expense that far exceeds even military spending.&lt;br /&gt;&lt;br /&gt;The two countries also agreed to a raft of measures, including creating and growing a cadre of field epidemiologists in India to prevent, detect, and respond to infectious disease threats. The US also pledged to engage with India on traditional medicine, health information systems, and agreed to launch a new collaboration on mental health. &lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 29264,
	&#039;title&#039; =&gt; &#039;India to supply generic cancer drug to US -Chidanand Rajghatta&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;WASHINGTON: &lt;/em&gt;India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered for increasing the price of life-saving drugs by as much as 5000 per cent overnight.&lt;br /&gt;
&lt;br /&gt;
Martin Shkreli, CEO of Turing Pharmaceuticals, is being dubbed the &#039;&#039;poster child for price gouging in the pharma industry&#039;&#039; and BBC has asked if he is the &#039;&#039;the most hated man in America&#039;&#039; after he bumped up the price of Daraprim, a drug used to treat a parasitic diseases, from an already high $13.50 to $750. Daily Beast called him an &#039;&#039;asshole.&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
Although Turing has walked back from the price rise in the face of public anger, his actions have drawn attention to the strategy adopted by Big Pharma to buy out older drugs that are nearing patent loss and hike their price massively, with the argument that the money is needed to fund new research.&lt;br /&gt;
&lt;br /&gt;
On Tuesday, Hillary Clinton stepped up to the plate, offering proposals to control drug prices, even as her challenger Bernie Sanders and others have called for eliminating corporate restrictions on generics. Such a move will help both American patients and Indian drug manufacturers, who have constrained by Big Pharma with the familiar argument that it needs to recoup money spent on research, and generic makers profit from the work of Big Pharma.&lt;br /&gt;
&lt;br /&gt;
The full details of the US-India agreement was not disclosed, but Indian officials confirmed that New Delhi had agreed to supply an &#039;&#039;off-patent&#039;&#039; cancer drug. Such a move could be a template for the supply of life-saving pharmaceuticals to a US system that is overpriced and overburdened, causing untold suffering to millions of poor and middleclass Americans.&lt;br /&gt;
&lt;br /&gt;
The Pharma lobby is the biggest contributor of money to the US political systems and it is widely believed that many lawmakers are beholden to it in lieu of campaign contributions.&lt;br /&gt;
&lt;br /&gt;
India is the second largest exporter of drugs to the United States. In 2014, India held 13% share of the total 64,170 imported lines of pharmaceuticals, according to a US fact sheet. The United States spends close to $3 trillion - some 17% of its GDP - on healthcare, an expense that far exceeds even military spending.&lt;br /&gt;
&lt;br /&gt;
The two countries also agreed to a raft of measures, including creating and growing a cadre of field epidemiologists in India to prevent, detect, and respond to infectious disease threats. The US also pledged to engage with India on traditional medicine, health information systems, and agreed to launch a new collaboration on mental health. &lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 24 September, 2015, http://timesofindia.indiatimes.com/india/India-to-supply-generic-cancer-drug-to-US/articleshow/49083996.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;india-to-supply-generic-cancer-drug-to-us-chidanand-rajghatta-4677319&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4677319,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 29264
$metaTitle = &#039;LATEST NEWS UPDATES | India to supply generic cancer drug to US -Chidanand Rajghatta&#039;
$metaKeywords = &#039;medicines,Access to Health,Access to Healthcare,generic drugs,generic medicines&#039;
$metaDesc = &#039;
-The Times of India

WASHINGTON: India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;br /&gt;&lt;br /&gt;&lt;em&gt;WASHINGTON: &lt;/em&gt;India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered for increasing the price of life-saving drugs by as much as 5000 per cent overnight.&lt;br /&gt;&lt;br /&gt;Martin Shkreli, CEO of Turing Pharmaceuticals, is being dubbed the &#039;&#039;poster child for price gouging in the pharma industry&#039;&#039; and BBC has asked if he is the &#039;&#039;the most hated man in America&#039;&#039; after he bumped up the price of Daraprim, a drug used to treat a parasitic diseases, from an already high $13.50 to $750. Daily Beast called him an &#039;&#039;asshole.&#039;&#039;&lt;br /&gt;&lt;br /&gt;Although Turing has walked back from the price rise in the face of public anger, his actions have drawn attention to the strategy adopted by Big Pharma to buy out older drugs that are nearing patent loss and hike their price massively, with the argument that the money is needed to fund new research.&lt;br /&gt;&lt;br /&gt;On Tuesday, Hillary Clinton stepped up to the plate, offering proposals to control drug prices, even as her challenger Bernie Sanders and others have called for eliminating corporate restrictions on generics. Such a move will help both American patients and Indian drug manufacturers, who have constrained by Big Pharma with the familiar argument that it needs to recoup money spent on research, and generic makers profit from the work of Big Pharma.&lt;br /&gt;&lt;br /&gt;The full details of the US-India agreement was not disclosed, but Indian officials confirmed that New Delhi had agreed to supply an &#039;&#039;off-patent&#039;&#039; cancer drug. Such a move could be a template for the supply of life-saving pharmaceuticals to a US system that is overpriced and overburdened, causing untold suffering to millions of poor and middleclass Americans.&lt;br /&gt;&lt;br /&gt;The Pharma lobby is the biggest contributor of money to the US political systems and it is widely believed that many lawmakers are beholden to it in lieu of campaign contributions.&lt;br /&gt;&lt;br /&gt;India is the second largest exporter of drugs to the United States. In 2014, India held 13% share of the total 64,170 imported lines of pharmaceuticals, according to a US fact sheet. The United States spends close to $3 trillion - some 17% of its GDP - on healthcare, an expense that far exceeds even military spending.&lt;br /&gt;&lt;br /&gt;The two countries also agreed to a raft of measures, including creating and growing a cadre of field epidemiologists in India to prevent, detect, and respond to infectious disease threats. The US also pledged to engage with India on traditional medicine, health information systems, and agreed to launch a new collaboration on mental health. &lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/india-to-supply-generic-cancer-drug-to-us-chidanand-rajghatta-4677319.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | India to supply generic cancer drug to US -Chidanand Rajghatta | Im4change.org</title>
    <meta name="description" content="
-The Times of India

WASHINGTON: India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>India to supply generic cancer drug to US -Chidanand Rajghatta</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India<br /><br /><em>WASHINGTON: </em>India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered for increasing the price of life-saving drugs by as much as 5000 per cent overnight.<br /><br />Martin Shkreli, CEO of Turing Pharmaceuticals, is being dubbed the ''poster child for price gouging in the pharma industry'' and BBC has asked if he is the ''the most hated man in America'' after he bumped up the price of Daraprim, a drug used to treat a parasitic diseases, from an already high $13.50 to $750. Daily Beast called him an ''asshole.''<br /><br />Although Turing has walked back from the price rise in the face of public anger, his actions have drawn attention to the strategy adopted by Big Pharma to buy out older drugs that are nearing patent loss and hike their price massively, with the argument that the money is needed to fund new research.<br /><br />On Tuesday, Hillary Clinton stepped up to the plate, offering proposals to control drug prices, even as her challenger Bernie Sanders and others have called for eliminating corporate restrictions on generics. Such a move will help both American patients and Indian drug manufacturers, who have constrained by Big Pharma with the familiar argument that it needs to recoup money spent on research, and generic makers profit from the work of Big Pharma.<br /><br />The full details of the US-India agreement was not disclosed, but Indian officials confirmed that New Delhi had agreed to supply an ''off-patent'' cancer drug. Such a move could be a template for the supply of life-saving pharmaceuticals to a US system that is overpriced and overburdened, causing untold suffering to millions of poor and middleclass Americans.<br /><br />The Pharma lobby is the biggest contributor of money to the US political systems and it is widely believed that many lawmakers are beholden to it in lieu of campaign contributions.<br /><br />India is the second largest exporter of drugs to the United States. In 2014, India held 13% share of the total 64,170 imported lines of pharmaceuticals, according to a US fact sheet. The United States spends close to $3 trillion - some 17% of its GDP - on healthcare, an expense that far exceeds even military spending.<br /><br />The two countries also agreed to a raft of measures, including creating and growing a cadre of field epidemiologists in India to prevent, detect, and respond to infectious disease threats. The US also pledged to engage with India on traditional medicine, health information systems, and agreed to launch a new collaboration on mental health. <br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f6df310dc35-trace').style.display = (document.getElementById('cakeErr67f6df310dc35-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f6df310dc35-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f6df310dc35-code').style.display = (document.getElementById('cakeErr67f6df310dc35-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f6df310dc35-context').style.display = (document.getElementById('cakeErr67f6df310dc35-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f6df310dc35-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f6df310dc35-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 29264,
		&#039;title&#039; =&gt; &#039;India to supply generic cancer drug to US -Chidanand Rajghatta&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;WASHINGTON: &lt;/em&gt;India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered for increasing the price of life-saving drugs by as much as 5000 per cent overnight.&lt;br /&gt;
&lt;br /&gt;
Martin Shkreli, CEO of Turing Pharmaceuticals, is being dubbed the &#039;&#039;poster child for price gouging in the pharma industry&#039;&#039; and BBC has asked if he is the &#039;&#039;the most hated man in America&#039;&#039; after he bumped up the price of Daraprim, a drug used to treat a parasitic diseases, from an already high $13.50 to $750. Daily Beast called him an &#039;&#039;asshole.&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
Although Turing has walked back from the price rise in the face of public anger, his actions have drawn attention to the strategy adopted by Big Pharma to buy out older drugs that are nearing patent loss and hike their price massively, with the argument that the money is needed to fund new research.&lt;br /&gt;
&lt;br /&gt;
On Tuesday, Hillary Clinton stepped up to the plate, offering proposals to control drug prices, even as her challenger Bernie Sanders and others have called for eliminating corporate restrictions on generics. Such a move will help both American patients and Indian drug manufacturers, who have constrained by Big Pharma with the familiar argument that it needs to recoup money spent on research, and generic makers profit from the work of Big Pharma.&lt;br /&gt;
&lt;br /&gt;
The full details of the US-India agreement was not disclosed, but Indian officials confirmed that New Delhi had agreed to supply an &#039;&#039;off-patent&#039;&#039; cancer drug. Such a move could be a template for the supply of life-saving pharmaceuticals to a US system that is overpriced and overburdened, causing untold suffering to millions of poor and middleclass Americans.&lt;br /&gt;
&lt;br /&gt;
The Pharma lobby is the biggest contributor of money to the US political systems and it is widely believed that many lawmakers are beholden to it in lieu of campaign contributions.&lt;br /&gt;
&lt;br /&gt;
India is the second largest exporter of drugs to the United States. In 2014, India held 13% share of the total 64,170 imported lines of pharmaceuticals, according to a US fact sheet. The United States spends close to $3 trillion - some 17% of its GDP - on healthcare, an expense that far exceeds even military spending.&lt;br /&gt;
&lt;br /&gt;
The two countries also agreed to a raft of measures, including creating and growing a cadre of field epidemiologists in India to prevent, detect, and respond to infectious disease threats. The US also pledged to engage with India on traditional medicine, health information systems, and agreed to launch a new collaboration on mental health. &lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 24 September, 2015, http://timesofindia.indiatimes.com/india/India-to-supply-generic-cancer-drug-to-US/articleshow/49083996.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;india-to-supply-generic-cancer-drug-to-us-chidanand-rajghatta-4677319&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4677319,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 29264,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | India to supply generic cancer drug to US -Chidanand Rajghatta&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Access to Health,Access to Healthcare,generic drugs,generic medicines&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India

WASHINGTON: India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;br /&gt;&lt;br /&gt;&lt;em&gt;WASHINGTON: &lt;/em&gt;India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered for increasing the price of life-saving drugs by as much as 5000 per cent overnight.&lt;br /&gt;&lt;br /&gt;Martin Shkreli, CEO of Turing Pharmaceuticals, is being dubbed the &#039;&#039;poster child for price gouging in the pharma industry&#039;&#039; and BBC has asked if he is the &#039;&#039;the most hated man in America&#039;&#039; after he bumped up the price of Daraprim, a drug used to treat a parasitic diseases, from an already high $13.50 to $750. Daily Beast called him an &#039;&#039;asshole.&#039;&#039;&lt;br /&gt;&lt;br /&gt;Although Turing has walked back from the price rise in the face of public anger, his actions have drawn attention to the strategy adopted by Big Pharma to buy out older drugs that are nearing patent loss and hike their price massively, with the argument that the money is needed to fund new research.&lt;br /&gt;&lt;br /&gt;On Tuesday, Hillary Clinton stepped up to the plate, offering proposals to control drug prices, even as her challenger Bernie Sanders and others have called for eliminating corporate restrictions on generics. Such a move will help both American patients and Indian drug manufacturers, who have constrained by Big Pharma with the familiar argument that it needs to recoup money spent on research, and generic makers profit from the work of Big Pharma.&lt;br /&gt;&lt;br /&gt;The full details of the US-India agreement was not disclosed, but Indian officials confirmed that New Delhi had agreed to supply an &#039;&#039;off-patent&#039;&#039; cancer drug. Such a move could be a template for the supply of life-saving pharmaceuticals to a US system that is overpriced and overburdened, causing untold suffering to millions of poor and middleclass Americans.&lt;br /&gt;&lt;br /&gt;The Pharma lobby is the biggest contributor of money to the US political systems and it is widely believed that many lawmakers are beholden to it in lieu of campaign contributions.&lt;br /&gt;&lt;br /&gt;India is the second largest exporter of drugs to the United States. In 2014, India held 13% share of the total 64,170 imported lines of pharmaceuticals, according to a US fact sheet. The United States spends close to $3 trillion - some 17% of its GDP - on healthcare, an expense that far exceeds even military spending.&lt;br /&gt;&lt;br /&gt;The two countries also agreed to a raft of measures, including creating and growing a cadre of field epidemiologists in India to prevent, detect, and respond to infectious disease threats. The US also pledged to engage with India on traditional medicine, health information systems, and agreed to launch a new collaboration on mental health. &lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 29264,
	&#039;title&#039; =&gt; &#039;India to supply generic cancer drug to US -Chidanand Rajghatta&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;WASHINGTON: &lt;/em&gt;India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered for increasing the price of life-saving drugs by as much as 5000 per cent overnight.&lt;br /&gt;
&lt;br /&gt;
Martin Shkreli, CEO of Turing Pharmaceuticals, is being dubbed the &#039;&#039;poster child for price gouging in the pharma industry&#039;&#039; and BBC has asked if he is the &#039;&#039;the most hated man in America&#039;&#039; after he bumped up the price of Daraprim, a drug used to treat a parasitic diseases, from an already high $13.50 to $750. Daily Beast called him an &#039;&#039;asshole.&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
Although Turing has walked back from the price rise in the face of public anger, his actions have drawn attention to the strategy adopted by Big Pharma to buy out older drugs that are nearing patent loss and hike their price massively, with the argument that the money is needed to fund new research.&lt;br /&gt;
&lt;br /&gt;
On Tuesday, Hillary Clinton stepped up to the plate, offering proposals to control drug prices, even as her challenger Bernie Sanders and others have called for eliminating corporate restrictions on generics. Such a move will help both American patients and Indian drug manufacturers, who have constrained by Big Pharma with the familiar argument that it needs to recoup money spent on research, and generic makers profit from the work of Big Pharma.&lt;br /&gt;
&lt;br /&gt;
The full details of the US-India agreement was not disclosed, but Indian officials confirmed that New Delhi had agreed to supply an &#039;&#039;off-patent&#039;&#039; cancer drug. Such a move could be a template for the supply of life-saving pharmaceuticals to a US system that is overpriced and overburdened, causing untold suffering to millions of poor and middleclass Americans.&lt;br /&gt;
&lt;br /&gt;
The Pharma lobby is the biggest contributor of money to the US political systems and it is widely believed that many lawmakers are beholden to it in lieu of campaign contributions.&lt;br /&gt;
&lt;br /&gt;
India is the second largest exporter of drugs to the United States. In 2014, India held 13% share of the total 64,170 imported lines of pharmaceuticals, according to a US fact sheet. The United States spends close to $3 trillion - some 17% of its GDP - on healthcare, an expense that far exceeds even military spending.&lt;br /&gt;
&lt;br /&gt;
The two countries also agreed to a raft of measures, including creating and growing a cadre of field epidemiologists in India to prevent, detect, and respond to infectious disease threats. The US also pledged to engage with India on traditional medicine, health information systems, and agreed to launch a new collaboration on mental health. &lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 24 September, 2015, http://timesofindia.indiatimes.com/india/India-to-supply-generic-cancer-drug-to-US/articleshow/49083996.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;india-to-supply-generic-cancer-drug-to-us-chidanand-rajghatta-4677319&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4677319,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 29264
$metaTitle = &#039;LATEST NEWS UPDATES | India to supply generic cancer drug to US -Chidanand Rajghatta&#039;
$metaKeywords = &#039;medicines,Access to Health,Access to Healthcare,generic drugs,generic medicines&#039;
$metaDesc = &#039;
-The Times of India

WASHINGTON: India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;br /&gt;&lt;br /&gt;&lt;em&gt;WASHINGTON: &lt;/em&gt;India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered for increasing the price of life-saving drugs by as much as 5000 per cent overnight.&lt;br /&gt;&lt;br /&gt;Martin Shkreli, CEO of Turing Pharmaceuticals, is being dubbed the &#039;&#039;poster child for price gouging in the pharma industry&#039;&#039; and BBC has asked if he is the &#039;&#039;the most hated man in America&#039;&#039; after he bumped up the price of Daraprim, a drug used to treat a parasitic diseases, from an already high $13.50 to $750. Daily Beast called him an &#039;&#039;asshole.&#039;&#039;&lt;br /&gt;&lt;br /&gt;Although Turing has walked back from the price rise in the face of public anger, his actions have drawn attention to the strategy adopted by Big Pharma to buy out older drugs that are nearing patent loss and hike their price massively, with the argument that the money is needed to fund new research.&lt;br /&gt;&lt;br /&gt;On Tuesday, Hillary Clinton stepped up to the plate, offering proposals to control drug prices, even as her challenger Bernie Sanders and others have called for eliminating corporate restrictions on generics. Such a move will help both American patients and Indian drug manufacturers, who have constrained by Big Pharma with the familiar argument that it needs to recoup money spent on research, and generic makers profit from the work of Big Pharma.&lt;br /&gt;&lt;br /&gt;The full details of the US-India agreement was not disclosed, but Indian officials confirmed that New Delhi had agreed to supply an &#039;&#039;off-patent&#039;&#039; cancer drug. Such a move could be a template for the supply of life-saving pharmaceuticals to a US system that is overpriced and overburdened, causing untold suffering to millions of poor and middleclass Americans.&lt;br /&gt;&lt;br /&gt;The Pharma lobby is the biggest contributor of money to the US political systems and it is widely believed that many lawmakers are beholden to it in lieu of campaign contributions.&lt;br /&gt;&lt;br /&gt;India is the second largest exporter of drugs to the United States. In 2014, India held 13% share of the total 64,170 imported lines of pharmaceuticals, according to a US fact sheet. The United States spends close to $3 trillion - some 17% of its GDP - on healthcare, an expense that far exceeds even military spending.&lt;br /&gt;&lt;br /&gt;The two countries also agreed to a raft of measures, including creating and growing a cadre of field epidemiologists in India to prevent, detect, and respond to infectious disease threats. The US also pledged to engage with India on traditional medicine, health information systems, and agreed to launch a new collaboration on mental health. &lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/india-to-supply-generic-cancer-drug-to-us-chidanand-rajghatta-4677319.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | India to supply generic cancer drug to US -Chidanand Rajghatta | Im4change.org</title>
    <meta name="description" content="
-The Times of India

WASHINGTON: India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>India to supply generic cancer drug to US -Chidanand Rajghatta</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India<br /><br /><em>WASHINGTON: </em>India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered for increasing the price of life-saving drugs by as much as 5000 per cent overnight.<br /><br />Martin Shkreli, CEO of Turing Pharmaceuticals, is being dubbed the ''poster child for price gouging in the pharma industry'' and BBC has asked if he is the ''the most hated man in America'' after he bumped up the price of Daraprim, a drug used to treat a parasitic diseases, from an already high $13.50 to $750. Daily Beast called him an ''asshole.''<br /><br />Although Turing has walked back from the price rise in the face of public anger, his actions have drawn attention to the strategy adopted by Big Pharma to buy out older drugs that are nearing patent loss and hike their price massively, with the argument that the money is needed to fund new research.<br /><br />On Tuesday, Hillary Clinton stepped up to the plate, offering proposals to control drug prices, even as her challenger Bernie Sanders and others have called for eliminating corporate restrictions on generics. Such a move will help both American patients and Indian drug manufacturers, who have constrained by Big Pharma with the familiar argument that it needs to recoup money spent on research, and generic makers profit from the work of Big Pharma.<br /><br />The full details of the US-India agreement was not disclosed, but Indian officials confirmed that New Delhi had agreed to supply an ''off-patent'' cancer drug. Such a move could be a template for the supply of life-saving pharmaceuticals to a US system that is overpriced and overburdened, causing untold suffering to millions of poor and middleclass Americans.<br /><br />The Pharma lobby is the biggest contributor of money to the US political systems and it is widely believed that many lawmakers are beholden to it in lieu of campaign contributions.<br /><br />India is the second largest exporter of drugs to the United States. In 2014, India held 13% share of the total 64,170 imported lines of pharmaceuticals, according to a US fact sheet. The United States spends close to $3 trillion - some 17% of its GDP - on healthcare, an expense that far exceeds even military spending.<br /><br />The two countries also agreed to a raft of measures, including creating and growing a cadre of field epidemiologists in India to prevent, detect, and respond to infectious disease threats. The US also pledged to engage with India on traditional medicine, health information systems, and agreed to launch a new collaboration on mental health. <br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f6df310dc35-trace').style.display = (document.getElementById('cakeErr67f6df310dc35-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f6df310dc35-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f6df310dc35-code').style.display = (document.getElementById('cakeErr67f6df310dc35-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f6df310dc35-context').style.display = (document.getElementById('cakeErr67f6df310dc35-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f6df310dc35-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f6df310dc35-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 29264,
		&#039;title&#039; =&gt; &#039;India to supply generic cancer drug to US -Chidanand Rajghatta&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;WASHINGTON: &lt;/em&gt;India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered for increasing the price of life-saving drugs by as much as 5000 per cent overnight.&lt;br /&gt;
&lt;br /&gt;
Martin Shkreli, CEO of Turing Pharmaceuticals, is being dubbed the &#039;&#039;poster child for price gouging in the pharma industry&#039;&#039; and BBC has asked if he is the &#039;&#039;the most hated man in America&#039;&#039; after he bumped up the price of Daraprim, a drug used to treat a parasitic diseases, from an already high $13.50 to $750. Daily Beast called him an &#039;&#039;asshole.&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
Although Turing has walked back from the price rise in the face of public anger, his actions have drawn attention to the strategy adopted by Big Pharma to buy out older drugs that are nearing patent loss and hike their price massively, with the argument that the money is needed to fund new research.&lt;br /&gt;
&lt;br /&gt;
On Tuesday, Hillary Clinton stepped up to the plate, offering proposals to control drug prices, even as her challenger Bernie Sanders and others have called for eliminating corporate restrictions on generics. Such a move will help both American patients and Indian drug manufacturers, who have constrained by Big Pharma with the familiar argument that it needs to recoup money spent on research, and generic makers profit from the work of Big Pharma.&lt;br /&gt;
&lt;br /&gt;
The full details of the US-India agreement was not disclosed, but Indian officials confirmed that New Delhi had agreed to supply an &#039;&#039;off-patent&#039;&#039; cancer drug. Such a move could be a template for the supply of life-saving pharmaceuticals to a US system that is overpriced and overburdened, causing untold suffering to millions of poor and middleclass Americans.&lt;br /&gt;
&lt;br /&gt;
The Pharma lobby is the biggest contributor of money to the US political systems and it is widely believed that many lawmakers are beholden to it in lieu of campaign contributions.&lt;br /&gt;
&lt;br /&gt;
India is the second largest exporter of drugs to the United States. In 2014, India held 13% share of the total 64,170 imported lines of pharmaceuticals, according to a US fact sheet. The United States spends close to $3 trillion - some 17% of its GDP - on healthcare, an expense that far exceeds even military spending.&lt;br /&gt;
&lt;br /&gt;
The two countries also agreed to a raft of measures, including creating and growing a cadre of field epidemiologists in India to prevent, detect, and respond to infectious disease threats. The US also pledged to engage with India on traditional medicine, health information systems, and agreed to launch a new collaboration on mental health. &lt;br /&gt;
&lt;/div&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Times of India, 24 September, 2015, http://timesofindia.indiatimes.com/india/India-to-supply-generic-cancer-drug-to-US/articleshow/49083996.cms&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;india-to-supply-generic-cancer-drug-to-us-chidanand-rajghatta-4677319&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 4677319,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 29264,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | India to supply generic cancer drug to US -Chidanand Rajghatta&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Access to Health,Access to Healthcare,generic drugs,generic medicines&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Times of India

WASHINGTON: India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;br /&gt;&lt;br /&gt;&lt;em&gt;WASHINGTON: &lt;/em&gt;India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered for increasing the price of life-saving drugs by as much as 5000 per cent overnight.&lt;br /&gt;&lt;br /&gt;Martin Shkreli, CEO of Turing Pharmaceuticals, is being dubbed the &#039;&#039;poster child for price gouging in the pharma industry&#039;&#039; and BBC has asked if he is the &#039;&#039;the most hated man in America&#039;&#039; after he bumped up the price of Daraprim, a drug used to treat a parasitic diseases, from an already high $13.50 to $750. Daily Beast called him an &#039;&#039;asshole.&#039;&#039;&lt;br /&gt;&lt;br /&gt;Although Turing has walked back from the price rise in the face of public anger, his actions have drawn attention to the strategy adopted by Big Pharma to buy out older drugs that are nearing patent loss and hike their price massively, with the argument that the money is needed to fund new research.&lt;br /&gt;&lt;br /&gt;On Tuesday, Hillary Clinton stepped up to the plate, offering proposals to control drug prices, even as her challenger Bernie Sanders and others have called for eliminating corporate restrictions on generics. Such a move will help both American patients and Indian drug manufacturers, who have constrained by Big Pharma with the familiar argument that it needs to recoup money spent on research, and generic makers profit from the work of Big Pharma.&lt;br /&gt;&lt;br /&gt;The full details of the US-India agreement was not disclosed, but Indian officials confirmed that New Delhi had agreed to supply an &#039;&#039;off-patent&#039;&#039; cancer drug. Such a move could be a template for the supply of life-saving pharmaceuticals to a US system that is overpriced and overburdened, causing untold suffering to millions of poor and middleclass Americans.&lt;br /&gt;&lt;br /&gt;The Pharma lobby is the biggest contributor of money to the US political systems and it is widely believed that many lawmakers are beholden to it in lieu of campaign contributions.&lt;br /&gt;&lt;br /&gt;India is the second largest exporter of drugs to the United States. In 2014, India held 13% share of the total 64,170 imported lines of pharmaceuticals, according to a US fact sheet. The United States spends close to $3 trillion - some 17% of its GDP - on healthcare, an expense that far exceeds even military spending.&lt;br /&gt;&lt;br /&gt;The two countries also agreed to a raft of measures, including creating and growing a cadre of field epidemiologists in India to prevent, detect, and respond to infectious disease threats. The US also pledged to engage with India on traditional medicine, health information systems, and agreed to launch a new collaboration on mental health. &lt;br /&gt;&lt;/div&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 29264,
	&#039;title&#039; =&gt; &#039;India to supply generic cancer drug to US -Chidanand Rajghatta&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div align=&quot;justify&quot;&gt;
-The Times of India&lt;br /&gt;
&lt;br /&gt;
&lt;em&gt;WASHINGTON: &lt;/em&gt;India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered for increasing the price of life-saving drugs by as much as 5000 per cent overnight.&lt;br /&gt;
&lt;br /&gt;
Martin Shkreli, CEO of Turing Pharmaceuticals, is being dubbed the &#039;&#039;poster child for price gouging in the pharma industry&#039;&#039; and BBC has asked if he is the &#039;&#039;the most hated man in America&#039;&#039; after he bumped up the price of Daraprim, a drug used to treat a parasitic diseases, from an already high $13.50 to $750. Daily Beast called him an &#039;&#039;asshole.&#039;&#039;&lt;br /&gt;
&lt;br /&gt;
Although Turing has walked back from the price rise in the face of public anger, his actions have drawn attention to the strategy adopted by Big Pharma to buy out older drugs that are nearing patent loss and hike their price massively, with the argument that the money is needed to fund new research.&lt;br /&gt;
&lt;br /&gt;
On Tuesday, Hillary Clinton stepped up to the plate, offering proposals to control drug prices, even as her challenger Bernie Sanders and others have called for eliminating corporate restrictions on generics. Such a move will help both American patients and Indian drug manufacturers, who have constrained by Big Pharma with the familiar argument that it needs to recoup money spent on research, and generic makers profit from the work of Big Pharma.&lt;br /&gt;
&lt;br /&gt;
The full details of the US-India agreement was not disclosed, but Indian officials confirmed that New Delhi had agreed to supply an &#039;&#039;off-patent&#039;&#039; cancer drug. Such a move could be a template for the supply of life-saving pharmaceuticals to a US system that is overpriced and overburdened, causing untold suffering to millions of poor and middleclass Americans.&lt;br /&gt;
&lt;br /&gt;
The Pharma lobby is the biggest contributor of money to the US political systems and it is widely believed that many lawmakers are beholden to it in lieu of campaign contributions.&lt;br /&gt;
&lt;br /&gt;
India is the second largest exporter of drugs to the United States. In 2014, India held 13% share of the total 64,170 imported lines of pharmaceuticals, according to a US fact sheet. The United States spends close to $3 trillion - some 17% of its GDP - on healthcare, an expense that far exceeds even military spending.&lt;br /&gt;
&lt;br /&gt;
The two countries also agreed to a raft of measures, including creating and growing a cadre of field epidemiologists in India to prevent, detect, and respond to infectious disease threats. The US also pledged to engage with India on traditional medicine, health information systems, and agreed to launch a new collaboration on mental health. &lt;br /&gt;
&lt;/div&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Times of India, 24 September, 2015, http://timesofindia.indiatimes.com/india/India-to-supply-generic-cancer-drug-to-US/articleshow/49083996.cms&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;india-to-supply-generic-cancer-drug-to-us-chidanand-rajghatta-4677319&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 4677319,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 29264
$metaTitle = &#039;LATEST NEWS UPDATES | India to supply generic cancer drug to US -Chidanand Rajghatta&#039;
$metaKeywords = &#039;medicines,Access to Health,Access to Healthcare,generic drugs,generic medicines&#039;
$metaDesc = &#039;
-The Times of India

WASHINGTON: India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered...&#039;
$disp = &#039;&lt;div align=&quot;justify&quot;&gt;-The Times of India&lt;br /&gt;&lt;br /&gt;&lt;em&gt;WASHINGTON: &lt;/em&gt;India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered for increasing the price of life-saving drugs by as much as 5000 per cent overnight.&lt;br /&gt;&lt;br /&gt;Martin Shkreli, CEO of Turing Pharmaceuticals, is being dubbed the &#039;&#039;poster child for price gouging in the pharma industry&#039;&#039; and BBC has asked if he is the &#039;&#039;the most hated man in America&#039;&#039; after he bumped up the price of Daraprim, a drug used to treat a parasitic diseases, from an already high $13.50 to $750. Daily Beast called him an &#039;&#039;asshole.&#039;&#039;&lt;br /&gt;&lt;br /&gt;Although Turing has walked back from the price rise in the face of public anger, his actions have drawn attention to the strategy adopted by Big Pharma to buy out older drugs that are nearing patent loss and hike their price massively, with the argument that the money is needed to fund new research.&lt;br /&gt;&lt;br /&gt;On Tuesday, Hillary Clinton stepped up to the plate, offering proposals to control drug prices, even as her challenger Bernie Sanders and others have called for eliminating corporate restrictions on generics. Such a move will help both American patients and Indian drug manufacturers, who have constrained by Big Pharma with the familiar argument that it needs to recoup money spent on research, and generic makers profit from the work of Big Pharma.&lt;br /&gt;&lt;br /&gt;The full details of the US-India agreement was not disclosed, but Indian officials confirmed that New Delhi had agreed to supply an &#039;&#039;off-patent&#039;&#039; cancer drug. Such a move could be a template for the supply of life-saving pharmaceuticals to a US system that is overpriced and overburdened, causing untold suffering to millions of poor and middleclass Americans.&lt;br /&gt;&lt;br /&gt;The Pharma lobby is the biggest contributor of money to the US political systems and it is widely believed that many lawmakers are beholden to it in lieu of campaign contributions.&lt;br /&gt;&lt;br /&gt;India is the second largest exporter of drugs to the United States. In 2014, India held 13% share of the total 64,170 imported lines of pharmaceuticals, according to a US fact sheet. The United States spends close to $3 trillion - some 17% of its GDP - on healthcare, an expense that far exceeds even military spending.&lt;br /&gt;&lt;br /&gt;The two countries also agreed to a raft of measures, including creating and growing a cadre of field epidemiologists in India to prevent, detect, and respond to infectious disease threats. The US also pledged to engage with India on traditional medicine, health information systems, and agreed to launch a new collaboration on mental health. &lt;br /&gt;&lt;/div&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/india-to-supply-generic-cancer-drug-to-us-chidanand-rajghatta-4677319.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | India to supply generic cancer drug to US -Chidanand Rajghatta | Im4change.org</title>
    <meta name="description" content="
-The Times of India

WASHINGTON: India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>India to supply generic cancer drug to US -Chidanand Rajghatta</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div align="justify">-The Times of India<br /><br /><em>WASHINGTON: </em>India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered for increasing the price of life-saving drugs by as much as 5000 per cent overnight.<br /><br />Martin Shkreli, CEO of Turing Pharmaceuticals, is being dubbed the ''poster child for price gouging in the pharma industry'' and BBC has asked if he is the ''the most hated man in America'' after he bumped up the price of Daraprim, a drug used to treat a parasitic diseases, from an already high $13.50 to $750. Daily Beast called him an ''asshole.''<br /><br />Although Turing has walked back from the price rise in the face of public anger, his actions have drawn attention to the strategy adopted by Big Pharma to buy out older drugs that are nearing patent loss and hike their price massively, with the argument that the money is needed to fund new research.<br /><br />On Tuesday, Hillary Clinton stepped up to the plate, offering proposals to control drug prices, even as her challenger Bernie Sanders and others have called for eliminating corporate restrictions on generics. Such a move will help both American patients and Indian drug manufacturers, who have constrained by Big Pharma with the familiar argument that it needs to recoup money spent on research, and generic makers profit from the work of Big Pharma.<br /><br />The full details of the US-India agreement was not disclosed, but Indian officials confirmed that New Delhi had agreed to supply an ''off-patent'' cancer drug. Such a move could be a template for the supply of life-saving pharmaceuticals to a US system that is overpriced and overburdened, causing untold suffering to millions of poor and middleclass Americans.<br /><br />The Pharma lobby is the biggest contributor of money to the US political systems and it is widely believed that many lawmakers are beholden to it in lieu of campaign contributions.<br /><br />India is the second largest exporter of drugs to the United States. In 2014, India held 13% share of the total 64,170 imported lines of pharmaceuticals, according to a US fact sheet. The United States spends close to $3 trillion - some 17% of its GDP - on healthcare, an expense that far exceeds even military spending.<br /><br />The two countries also agreed to a raft of measures, including creating and growing a cadre of field epidemiologists in India to prevent, detect, and respond to infectious disease threats. The US also pledged to engage with India on traditional medicine, health information systems, and agreed to launch a new collaboration on mental health. <br /></div>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 29264,
		'title' => 'India to supply generic cancer drug to US -Chidanand Rajghatta',
		'subheading' => '',
		'description' => '<div align="justify">
-The Times of India<br />
<br />
<em>WASHINGTON: </em>India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered for increasing the price of life-saving drugs by as much as 5000 per cent overnight.<br />
<br />
Martin Shkreli, CEO of Turing Pharmaceuticals, is being dubbed the ''poster child for price gouging in the pharma industry'' and BBC has asked if he is the ''the most hated man in America'' after he bumped up the price of Daraprim, a drug used to treat a parasitic diseases, from an already high $13.50 to $750. Daily Beast called him an ''asshole.''<br />
<br />
Although Turing has walked back from the price rise in the face of public anger, his actions have drawn attention to the strategy adopted by Big Pharma to buy out older drugs that are nearing patent loss and hike their price massively, with the argument that the money is needed to fund new research.<br />
<br />
On Tuesday, Hillary Clinton stepped up to the plate, offering proposals to control drug prices, even as her challenger Bernie Sanders and others have called for eliminating corporate restrictions on generics. Such a move will help both American patients and Indian drug manufacturers, who have constrained by Big Pharma with the familiar argument that it needs to recoup money spent on research, and generic makers profit from the work of Big Pharma.<br />
<br />
The full details of the US-India agreement was not disclosed, but Indian officials confirmed that New Delhi had agreed to supply an ''off-patent'' cancer drug. Such a move could be a template for the supply of life-saving pharmaceuticals to a US system that is overpriced and overburdened, causing untold suffering to millions of poor and middleclass Americans.<br />
<br />
The Pharma lobby is the biggest contributor of money to the US political systems and it is widely believed that many lawmakers are beholden to it in lieu of campaign contributions.<br />
<br />
India is the second largest exporter of drugs to the United States. In 2014, India held 13% share of the total 64,170 imported lines of pharmaceuticals, according to a US fact sheet. The United States spends close to $3 trillion - some 17% of its GDP - on healthcare, an expense that far exceeds even military spending.<br />
<br />
The two countries also agreed to a raft of measures, including creating and growing a cadre of field epidemiologists in India to prevent, detect, and respond to infectious disease threats. The US also pledged to engage with India on traditional medicine, health information systems, and agreed to launch a new collaboration on mental health. <br />
</div>',
		'credit_writer' => 'The Times of India, 24 September, 2015, http://timesofindia.indiatimes.com/india/India-to-supply-generic-cancer-drug-to-US/articleshow/49083996.cms',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'india-to-supply-generic-cancer-drug-to-us-chidanand-rajghatta-4677319',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 4677319,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 29264,
	'metaTitle' => 'LATEST NEWS UPDATES | India to supply generic cancer drug to US -Chidanand Rajghatta',
	'metaKeywords' => 'medicines,Access to Health,Access to Healthcare,generic drugs,generic medicines',
	'metaDesc' => '
-The Times of India

WASHINGTON: India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered...',
	'disp' => '<div align="justify">-The Times of India<br /><br /><em>WASHINGTON: </em>India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered for increasing the price of life-saving drugs by as much as 5000 per cent overnight.<br /><br />Martin Shkreli, CEO of Turing Pharmaceuticals, is being dubbed the ''poster child for price gouging in the pharma industry'' and BBC has asked if he is the ''the most hated man in America'' after he bumped up the price of Daraprim, a drug used to treat a parasitic diseases, from an already high $13.50 to $750. Daily Beast called him an ''asshole.''<br /><br />Although Turing has walked back from the price rise in the face of public anger, his actions have drawn attention to the strategy adopted by Big Pharma to buy out older drugs that are nearing patent loss and hike their price massively, with the argument that the money is needed to fund new research.<br /><br />On Tuesday, Hillary Clinton stepped up to the plate, offering proposals to control drug prices, even as her challenger Bernie Sanders and others have called for eliminating corporate restrictions on generics. Such a move will help both American patients and Indian drug manufacturers, who have constrained by Big Pharma with the familiar argument that it needs to recoup money spent on research, and generic makers profit from the work of Big Pharma.<br /><br />The full details of the US-India agreement was not disclosed, but Indian officials confirmed that New Delhi had agreed to supply an ''off-patent'' cancer drug. Such a move could be a template for the supply of life-saving pharmaceuticals to a US system that is overpriced and overburdened, causing untold suffering to millions of poor and middleclass Americans.<br /><br />The Pharma lobby is the biggest contributor of money to the US political systems and it is widely believed that many lawmakers are beholden to it in lieu of campaign contributions.<br /><br />India is the second largest exporter of drugs to the United States. In 2014, India held 13% share of the total 64,170 imported lines of pharmaceuticals, according to a US fact sheet. The United States spends close to $3 trillion - some 17% of its GDP - on healthcare, an expense that far exceeds even military spending.<br /><br />The two countries also agreed to a raft of measures, including creating and growing a cadre of field epidemiologists in India to prevent, detect, and respond to infectious disease threats. The US also pledged to engage with India on traditional medicine, health information systems, and agreed to launch a new collaboration on mental health. <br /></div>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 29264,
	'title' => 'India to supply generic cancer drug to US -Chidanand Rajghatta',
	'subheading' => '',
	'description' => '<div align="justify">
-The Times of India<br />
<br />
<em>WASHINGTON: </em>India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered for increasing the price of life-saving drugs by as much as 5000 per cent overnight.<br />
<br />
Martin Shkreli, CEO of Turing Pharmaceuticals, is being dubbed the ''poster child for price gouging in the pharma industry'' and BBC has asked if he is the ''the most hated man in America'' after he bumped up the price of Daraprim, a drug used to treat a parasitic diseases, from an already high $13.50 to $750. Daily Beast called him an ''asshole.''<br />
<br />
Although Turing has walked back from the price rise in the face of public anger, his actions have drawn attention to the strategy adopted by Big Pharma to buy out older drugs that are nearing patent loss and hike their price massively, with the argument that the money is needed to fund new research.<br />
<br />
On Tuesday, Hillary Clinton stepped up to the plate, offering proposals to control drug prices, even as her challenger Bernie Sanders and others have called for eliminating corporate restrictions on generics. Such a move will help both American patients and Indian drug manufacturers, who have constrained by Big Pharma with the familiar argument that it needs to recoup money spent on research, and generic makers profit from the work of Big Pharma.<br />
<br />
The full details of the US-India agreement was not disclosed, but Indian officials confirmed that New Delhi had agreed to supply an ''off-patent'' cancer drug. Such a move could be a template for the supply of life-saving pharmaceuticals to a US system that is overpriced and overburdened, causing untold suffering to millions of poor and middleclass Americans.<br />
<br />
The Pharma lobby is the biggest contributor of money to the US political systems and it is widely believed that many lawmakers are beholden to it in lieu of campaign contributions.<br />
<br />
India is the second largest exporter of drugs to the United States. In 2014, India held 13% share of the total 64,170 imported lines of pharmaceuticals, according to a US fact sheet. The United States spends close to $3 trillion - some 17% of its GDP - on healthcare, an expense that far exceeds even military spending.<br />
<br />
The two countries also agreed to a raft of measures, including creating and growing a cadre of field epidemiologists in India to prevent, detect, and respond to infectious disease threats. The US also pledged to engage with India on traditional medicine, health information systems, and agreed to launch a new collaboration on mental health. <br />
</div>',
	'credit_writer' => 'The Times of India, 24 September, 2015, http://timesofindia.indiatimes.com/india/India-to-supply-generic-cancer-drug-to-US/articleshow/49083996.cms',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'india-to-supply-generic-cancer-drug-to-us-chidanand-rajghatta-4677319',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 4677319,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {},
		(int) 2 => object(Cake\ORM\Entity) {},
		(int) 3 => object(Cake\ORM\Entity) {},
		(int) 4 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 29264
$metaTitle = 'LATEST NEWS UPDATES | India to supply generic cancer drug to US -Chidanand Rajghatta'
$metaKeywords = 'medicines,Access to Health,Access to Healthcare,generic drugs,generic medicines'
$metaDesc = '
-The Times of India

WASHINGTON: India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered...'
$disp = '<div align="justify">-The Times of India<br /><br /><em>WASHINGTON: </em>India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered for increasing the price of life-saving drugs by as much as 5000 per cent overnight.<br /><br />Martin Shkreli, CEO of Turing Pharmaceuticals, is being dubbed the ''poster child for price gouging in the pharma industry'' and BBC has asked if he is the ''the most hated man in America'' after he bumped up the price of Daraprim, a drug used to treat a parasitic diseases, from an already high $13.50 to $750. Daily Beast called him an ''asshole.''<br /><br />Although Turing has walked back from the price rise in the face of public anger, his actions have drawn attention to the strategy adopted by Big Pharma to buy out older drugs that are nearing patent loss and hike their price massively, with the argument that the money is needed to fund new research.<br /><br />On Tuesday, Hillary Clinton stepped up to the plate, offering proposals to control drug prices, even as her challenger Bernie Sanders and others have called for eliminating corporate restrictions on generics. Such a move will help both American patients and Indian drug manufacturers, who have constrained by Big Pharma with the familiar argument that it needs to recoup money spent on research, and generic makers profit from the work of Big Pharma.<br /><br />The full details of the US-India agreement was not disclosed, but Indian officials confirmed that New Delhi had agreed to supply an ''off-patent'' cancer drug. Such a move could be a template for the supply of life-saving pharmaceuticals to a US system that is overpriced and overburdened, causing untold suffering to millions of poor and middleclass Americans.<br /><br />The Pharma lobby is the biggest contributor of money to the US political systems and it is widely believed that many lawmakers are beholden to it in lieu of campaign contributions.<br /><br />India is the second largest exporter of drugs to the United States. In 2014, India held 13% share of the total 64,170 imported lines of pharmaceuticals, according to a US fact sheet. The United States spends close to $3 trillion - some 17% of its GDP - on healthcare, an expense that far exceeds even military spending.<br /><br />The two countries also agreed to a raft of measures, including creating and growing a cadre of field epidemiologists in India to prevent, detect, and respond to infectious disease threats. The US also pledged to engage with India on traditional medicine, health information systems, and agreed to launch a new collaboration on mental health. <br /></div>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

India to supply generic cancer drug to US -Chidanand Rajghatta

-The Times of India WASHINGTON: India has agreed to supply to the United States generic cancer drugs at a time there is outrage in America about the predatory practices by the US pharma industry, one of whose leaders is getting hammered for increasing the price of life-saving drugs by as much as 5000 per cent overnight. Martin Shkreli, CEO of Turing Pharmaceuticals, is being dubbed the ''poster child for price gouging in the pharma industry'' and BBC has asked if he is the ''the most hated man in America'' after he bumped up the price of Daraprim, a drug used to treat a parasitic diseases, from an already high $13.50 to $750. Daily Beast called him an ''asshole.'' Although Turing has walked back from the price rise in the face of public anger, his actions have drawn attention to the strategy adopted by Big Pharma to buy out older drugs that are nearing patent loss and hike their price massively, with the argument that the money is needed to fund new research. On Tuesday, Hillary Clinton stepped up to the plate, offering proposals to control drug prices, even as her challenger Bernie Sanders and others have called for eliminating corporate restrictions on generics. Such a move will help both American patients and Indian drug manufacturers, who have constrained by Big Pharma with the familiar argument that it needs to recoup money spent on research, and generic makers profit from the work of Big Pharma. The full details of the US-India agreement was not disclosed, but Indian officials confirmed that New Delhi had agreed to supply an ''off-patent'' cancer drug. Such a move could be a template for the supply of life-saving pharmaceuticals to a US system that is overpriced and overburdened, causing untold suffering to millions of poor and middleclass Americans. The Pharma lobby is the biggest contributor of money to the US political systems and it is widely believed that many lawmakers are beholden to it in lieu of campaign contributions. India is the second largest exporter of drugs to the United States. In 2014, India held 13% share of the total 64,170 imported lines of pharmaceuticals, according to a US fact sheet. The United States spends close to $3 trillion - some 17% of its GDP - on healthcare, an expense that far exceeds even military spending. The two countries also agreed to a raft of measures, including creating and growing a cadre of field epidemiologists in India to prevent, detect, and respond to infectious disease threats. The US also pledged to engage with India on traditional medicine, health information systems, and agreed to launch a new collaboration on mental health.